New app could help children with diabetes avoid dangerous blood sugar swings
NCT ID NCT07470905
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested DiaBuddy, a mobile app designed to help children with type 1 diabetes and their families make better decisions about insulin dosing and managing sick days. Twenty-five children aged 5 to 18 used the app for three months. The study found that the app's recommendations matched those of a specialist doctor and that using it was linked to improved blood sugar control and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- DiaBuddy mobile app (decision-support tool)
- What this could lead to
- If successful, this app could help children with type 1 diabetes and their families make safer insulin dosing and sick-day decisions at home, potentially improving blood sugar control and quality of life.
- What could go wrong
- This is a small pilot study with only 25 children, no control group, and short follow-up. The app's benefits may not hold up in larger, longer trials or in different settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
25 people
The number who actually took part.
- Started
-
Jul 2025
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
5 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosed Type 1 Diabetes Mellitus for more than 1 year Age 5 to 18 years Attending pediatric endocrinology outpatient clinic at Regency Center for Diabetes Endocrinology and Research, Kanpur Caregiver willing and able to use a smartphone application Written informed consent from parent or guardian and assent from participant where applicable Exclusion Criteria: * Type 2 diabetes or other forms of diabetes Significant comorbidity is known to independently affect glycemic control No smartphone access in the household Prior use of the DiaBuddy application Incomplete follow-up data at 3 months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Type 1 diabetes (T1D) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Regency Hospital
Kanpur, Uttar Pradesh, 208001, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Home c-peptide tests could reveal hidden insulin production in diabetes
- Tiny vesicles could hold the key to better islet transplants
- Can a bedtime snack tame overnight blood sugar swings in kids with diabetes?
- Can Open-Source insulin systems match commercial ones without meal announcements?
- A glucose Monitor's second chance: can it tame type 1 diabetes in High-Risk teens?
- AI takes the wheel: could a smart algorithm optimize insulin pumps from home?